The utilization of trifluorothymidine (TFT) to select for thymidine kinase-deficient (TK-/-) mutants from L5178Y/TK+/- mouse lymphoma cells. [electronic resource]
Producer: 19820109Description: 363-78 p. digitalISSN:- 0027-5107
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.